The chart demonstrates the changes in the proportions of sales distribution of a pharmaceutical comapany across three regions over a 5-year period spanning from 2022 to 2006
Overall, it is evident that Asia exhibited an upward trajectory in its sales proportion throughout the years, while Europe and America experienced the contrasting trend. America initially mainted the dominant, but Asia overtook it towards the end of the period
In 2002, America mainted the leading position, contributing aroung 41% of the company’s total sales. However, it decreased gradually, reaching its peak of 27% in 2004, before recoving and accounting for 30% at the end of the period. Whereas, America ranked the second position in 2002, making up 30% of total sales, after which it rose consistently. Despite attaining the highest point of 38% in 2004, it displayed a decrease trend, ending at 30% in 2006, equalling that of America in this year.
On the other hand, Asia followed a reverse trajectory in its total sales, starting at a quarter in 2002 and surpassing that of America in 2005. Then, it rose gradually, accounting for 40% in 2006, matching America’s initial proportion.